Akeso speeds up antibody production in China with GE’s platform
GE to set up its FlexFactory platform for antibody manufacturing at Akeso’s facility in Guangzhou, aiming to optimize the latter’s biologics production.
Archives for November 19, 2019
Teva launches biosimilar rival to Roche's Rituxan with 10% discount
Teva and Celltrion Healthcare launch the first biosimilar rival to Roche’s Rituxan in the US.
Forty Seven ramps up contract manufacturing spending
Forty Seven records 50% increase in R&D spending, as contract manufacturing costs ramp up.